C12N 2770/24232
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2770/24232 (Use of virus as therapeutic agent, other than vaccine) appears on 6 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 9
- Assignees
- 5
- Inventors
- 16
- Latest grant
- 28 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 3 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 2 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Regulatable cell surface receptors and related compositions and methods28 Oct 2025US 12,454,562 B2The Board of Trustees of the Leland Stanford Junior University
- Composition comprising NC886 for improving oncolytic virus activity or production26 Aug 2025US 12,398,376 B2National Cancer Center
- Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling2 Jul 2024US 12,023,375 B2University of Washington
- Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling10 May 2022US 11,324,817 B2University of Washington through its Center for Commercialization
- Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling8 Oct 2019US 10,434,164 B2University of Washington through its Center for Commercialization
- Regulatable Cell Surface Receptors and Related Compositions and Methods19 Mar 2026US 2026/0078164 A1The Board of Trustees of the Leland Stanford Junior University
- Anti-viral peptide compositions and methods to improve biological activity thereof11 Sep 2025US 2025/0282830 A1Nanyang Technological University
- Methods and Compositions for Activation of Innate Immune Responses Through RIG-I Like Receptor Signaling20 Oct 2022US 2022/0331418 A1University of Washington through its Center for Commercialization
- Regulatable cell surface receptors and related compositions and methods10 Feb 2022US 2022/0041686 A1The Board of Trustees of the Leland Stanford Junior University
- Composition comprising nc886 for improving oncolytic virus activity or production27 Jan 2022US 2022/0025338 A1National Cancer Center
Most cited
By later US patents
- Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling2US 10,434,164 B2University of Washington through its Center for Commercialization · 2019
- Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling2US 9,775,894 B2University of Washington through its Center for Commercialization · 2017